Dong-A ST Rises 0.72% Amid Uptrend in Biosimilar (Generic Biopharmaceutical) Theme

On the 5th, the biosimilar (generic biopharmaceutical) theme rose 3.84% compared to the previous day, showing strength, while Dong-A ST, a related stock attracting attention, surged 0.72% compared to the previous day. Dong-A ST is known as a pharmaceutical company listed through a corporate spin-off from Dong-A Pharmaceutical.

[Graph] Major stock price changes in the biosimilar (generic biopharmaceutical) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Dong-A ST ranked first in quant financial ranking (out of 17 stocks) by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Dong-A ST having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.